Neurofibromatosis Type 2

Overview


Tumour Group: Other Brain Tumours and Related Conditions
WHO Grade:  
Prevalence/Incidence:  
Typical Age Range:  

Contents
Description of Tumour
Symptoms
Treatment / Standard of Care
Prognosis
References

Description of Tumour


Neurofibromatosis Type 2 is an autosomal dominant disorder that is passed from one generation to the next but in 50% of the cases it is a spontaneous new mutation. It is usually diagnosed by the presence of acoustic neuromas (schwannomas) arising on both the right and left vestibular-cochlear nerves and patients often present with deafness. The second most common type of brain tumour in children with this disorder is meningiomas.

Symptoms


Information to come.

Treatment / Standard of Care


Information to come.

Prognosis  


A prognosis is an estimate of the likely progress of a disease after a diagnosis, based on an average patient group. Since every person is different, please take time to talk with your health care team about how this information applies to you.

By clicking on 'Expand,' a statistic on the prognosis for Neurofibromatosis Type 2 will be shown.

Expand for Prognosis Information

For brain tumour patients, a prognosis depends on several factors, which can include age and other health issues, the size of the tumour, its molecular profile, the type of tumour, how much can be removed, and its response to treatments such as chemotherapy and radiation therapy.

Information to come.

References


Image credited to The Armed Forces Institute of Pathology [Public domain], via Wikimedia Commons

 

When Tanya was diagnosed with multiple brain tumours at the age of 40, she was shocked. Falling sick had been the furthest thing from her mind. An active and independent woman, she was scared but also determined to live the best life possible. A CT scan and MRI lead to the discovery of nine tumours of varying types, locations and sizes on her brain. This was soon diagnosed as Neurofibromatosis Type 2. 

Read about Tanya and her journey in this inspiring story of strength >>

 

Share This

Featured Story

Make every brain tumour count

Stephanie, a 38-year-old mother of twins has been diagnosed with an extremely rare and inoperable brain tumour - a rosette-forming glioneuronal tumour, a type of tumour that little is known about and cannot be removed due to its location in her brain. This reality does not stop Stephanie from her tireless efforts to reduce the stigma of having a brain tumour. Learn why Stephanie is urging all Canadians to make every brain tumour count.

Learn more

Spotlight

Piper's Story: a dream more precious than Olympic gold

Hi, I am Piper Gilles. You may know me as a world-famous ice dancer. I competed in the PyeongChang 2018 Olympic Winter Games. I am a 7...

Learn more

Doug's Adventure

I am Doug, I have brain cancer; I am told it is terminal, but the “good” kind of terminal. I can assure you that receiving that news...

Learn more

Upcoming Events

  • 17/Jul/2019: Niagara Region Support Group: Meets at Wellspring Niagara, 3250 Schmon Parkway, Thorold, ON, L2V 4Y6... Learn more >
  • 18/Jul/2019: Virtual Support Group East: Virtual Support Group for Eastern Canada... Learn more >
  • 20/Jul/2019: Rebounders - LdnOnt: First Baptist Church, 568 Richmond St, London, ON... Learn more >
  • 20/Jul/2019: BrainWAVE ON 2019 Toronto Football: BMO Field Exhibition Place, Toronto, ON... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2019 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001